Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00087009
Status:
TERMINATED
Last Update Posted:
2013-03-19
First Post:
2004-07-08
Brief Title:
Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-05
Start Date Type:
None
Primary Completion Date:
2008-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-08
Completion Date Type:
ACTUAL
First Submit Date:
2004-07-08
First Submit QC Date:
July 9 2004
Study First Post Date:
2004-07-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-03-18
Last Update Post Date:
2013-03-19
Last Update Post Date Type:
ESTIMATED